학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 20건 | 목록 1~10
Academic Journal
Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; The George Institute for Global Health, Sydney, Australia. Electronic address: h.j.lambers.heerspink@umcg.nl.; Little DJ; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.; Frison L; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wanner C; Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.; Jongs N; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Postmus D; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1755 (Electronic) Linking ISSN: 00852538 NLM ISO Abbreviation: Kidney Int Subsets: MEDLINE
Academic Journal
Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Mogensen UM; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark.; Talebi A; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Campbell RT; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; de Boer RA; Erasmus Medical Center, Rotterdam, the Netherlands.; Inzucchi SE; Yale School of Medicine, New Haven, Connecticut, USA.; Køber L; Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA.; Martinez FA; University of Cordoba, Cordoba, Argentina.; Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Sjöstrand M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Academic Journal
Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Yang M; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.; Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; McCausland FR; Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Tolomeo P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Vadagunathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. john.mcmurray@glasgow.ac.uk.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; The George Institute for Global Health, Sydney, New South Wales, Australia.; Jongs N; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Schloemer P; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany.; Little DJ; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Brinker M; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany.; Tasto C; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany.; Karpefors M; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wheeler DC; The George Institute for Global Health, Sydney, New South Wales, Australia.; Department of Renal Medicine, University College London, London, United Kingdom.; Bakris G; Department of Medicine, University of Chicago Medicine, Chicago, Illinois.; Perkovic V; The George Institute for Global Health, Sydney, New South Wales, Australia.; Faculty of Medicine & Health, University New South Wales, Sydney, New South Wales, Australia.; Nkulikiyinka R; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany.; Rossert J; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE
Academic Journal
Little DJ; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Schloemer P; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany.; Jongs N; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Brinker M; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany.; Karpefors M; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Tasto C; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany.; Rethemeier N; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany.; Frison L; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Nkulikiyinka R; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany.; Rossert J; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; The George Institute for Global Health, Sydney, New South Wales, Australia.
Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE
Academic Journal
Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston.; de Boer RA; University of Groningen, Groningen, the Netherlands.; Hernandez AF; Duke University Medical Center, Durham, NC.; Inzucchi SE; Yale School of Medicine, New Haven, CT.; Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO.; Køber L; Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen.; Lam CSP; National Heart Centre Singapore & Duke-National University of Singapore, Singapore.; Langkilde AM; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Martinez FA; University of Cordoba, Cordoba, Argentina.; Petersson M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Ponikowski P; Department of Heart Disease, Wroclaw Medical University, Wroclaw, Poland.; Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston.; Shah SJ; Northwestern University Feinberg School of Medicine, Chicago.; Sjostrand M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wilderang U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE
Academic Journal
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; Talebi A; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wei LJ; Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; McCaw ZR; Insitro, South San Francisco, California.; Wilderäng U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; Petersson M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Langkilde AM; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; de Boer RA; Erasmus Medical Center, Rotterdam, the Netherlands.; Hernandez AF; Duke University Medical Center, Durham, North Carolina.; Associate Editor, JAMA Cardiology.; Inzucchi SE; Yale School of Medicine, New Haven, Connecticut.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City.; Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore.; Martinez FA; University of Cordoba, Cordoba, Argentina.; Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois.; Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE
Academic Journal
Karpefors M; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publisher: SAGE Publications Country of Publication: England NLM ID: 101197451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-7753 (Electronic) Linking ISSN: 17407745 NLM ISO Abbreviation: Clin Trials Subsets: MEDLINE
Academic Journal
Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Samvel.gasparyan@astrazeneca.com.; Buenconsejo J; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kowalewski EK; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Oscarsson J; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Bengtsson OF; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Esterline R; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Koch GG; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Berwanger O; Academic Research Organization (ARO), Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.
Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Gasparyan SB
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어